Clonazolam

Clonazolam
Clinical data
Dependence; liability	Very high
Routes of; administration	Oral
Legal status
Legal status	BR: Class B1 (Psychoactive drugs); DE: Anlage II (Authorized trade only, not prescriptible); UK: Class C; US: Schedule I; Illegal in Sweden;
Identifiers
	IUPAC name 6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine;
CAS Number	33887-02-4;
PubChem CID	12317881;
ChemSpider	15468596;
UNII	HJH52YYC1X;
KEGG	C22814;
CompTox Dashboard (EPA)	DTXSID301014166 ;
Chemical and physical data
Formula	C17H12ClN5O2
Molar mass	353.77 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1=NN=C2N1C3=C(C=C(C=C3)[N+](=O)[O-])C(=NC2)C4=CC=CC=C4Cl;
	InChI InChI=1S/C17H12ClN5O2/c1-10-20-21-16-9-19-17(12-4-2-3-5-14(12)18)13-8-11(23(24)25)6-7-15(13)22(10)16/h2-8H,9H2,1H3; Key:XJRGLCAWBRZUFC-UHFFFAOYSA-N;

Clonazolam (also known as clonitrazolam) is a drug of the triazolobenzodiazepine (TBZD) class, which are benzodiazepines (BZDs) fused with a triazole ring. Although little research has been done about its effects and metabolism, it is sold online as a designer drug.

The synthesis of clonazolam was first reported in 1971 and the drug was described as the most active compound in the series tested.

Depending on dose consumed, clonazolam may pose comparatively higher risk than other designer benzodiazepines due to its ability to produce strong sedation and amnesia at doses as small as 0.5 mg.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.